ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
1 hedge funds and large institutions have $239K invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
1,506% more capital invested
Capital invested by funds: $14.9K → $239K (+$224K)
1.06% more ownership
Funds ownership: 0.09% → 1.15% (+1.1%)
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$214K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$14.9K |
IWFL Hedge Fund Activity: Q1 2023 in Review
1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q1 2023, worth a combined $239K — up 1,506% from $14.9K a quarter earlier.
Fund positioning in IWFL was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was IMC Chicago, opening a new position worth an estimated $214K. The largest seller was UBS Group, exiting entirely with an estimated $14.9K sold.
- 1 institutional investor held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $239K of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q1 2023, up 1,506% quarter-over-quarter.
- 1 fund opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN buyer in Q1 2023 was IMC Chicago, an estimated $214K added.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN seller in Q1 2023 was UBS Group, an estimated $14.9K sold.
Based on aggregated 13F filings for Q1 2023.